Multiple pathways have been found to increase cancer progression and metastasis including the activation of the PI3K/AKT pathway2 and the gain-of-function mutation of the tumour suppressor TP533, which are the two most frequent driving mutations in a broad variety of human cancers4. The gene discussed is AKT1; the disease is cancer.